A low-molecular-weight heparin markedly reduced osteolytic bone destruction in a mouse model of breast cancer bone metastases.




Kakonen SM, Mohammad KS, Kakonen RS, Marjamaki A, Warri A, Salmivirta M, Guise TA

PublisherAMER SOC BONE & MINERAL RES

2003

Journal of Bone and Mineral Research

JOURNAL OF BONE AND MINERAL RESEARCH

J BONE MINER RES

18

S63

S63

1

0884-0431




Last updated on 2024-26-11 at 20:44